tyramine has been researched along with nisoxetine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuller, RW; Perry, KW; Snoddy, HD | 1 |
Billings, R; Lemberger, L; Rowe, H; Terman, S | 1 |
D'Alonzo, AJ; Darbenzio, RB; Dorso, CR; Grover, GJ; Zhu, JL | 1 |
Chen, N; Justice, JB; Trowbridge, CG | 1 |
Danek Burgess, KS; Justice, JB | 1 |
1 trial(s) available for tyramine and nisoxetine
Article | Year |
---|---|
The effect of nisoxetine (Lilly compound 94939), a potential antidepressant, on biogenic amine uptake in man.
Topics: Adult; Antidepressive Agents; Biogenic Amines; Blood Platelets; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Fluoxetine; Heart Rate; Humans; Male; Norepinephrine; Phenyl Ethers; Propylamines; Serotonin; Tyramine | 1976 |
4 other study(ies) available for tyramine and nisoxetine
Article | Year |
---|---|
Nisoxetine antagonism of norepinephrine depletion in brain and heart after alpha-methyl-m-tyrosine administration.
Topics: Animals; Brain Chemistry; Fluoxetine; Male; Metaraminol; Methyltyrosines; Myocardium; Norepinephrine; Phenyl Ethers; Propylamines; Rats; Tyramine | 1979 |
Proarrhythmic effects of pinacidil are partially mediated through enhancement of catecholamine release in isolated perfused guinea-pig hearts.
Topics: Adenosine Triphosphate; Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Epinephrine; Fluoxetine; Glyburide; Guanidines; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Methoxamine; Myocardial Reperfusion Injury; Myocardium; Nadolol; Norepinephrine; Perfusion; Pinacidil; Potassium Channels; Tyramine | 1998 |
Voltammetric studies on mechanisms of dopamine efflux in the presence of substrates and cocaine from cells expressing human norepinephrine transporter.
Topics: Adrenergic Uptake Inhibitors; Animals; Binding, Competitive; Carrier Proteins; Cocaine; Desipramine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrophysiology; Enzyme Inhibitors; Fluoxetine; Humans; Ionophores; Kinetics; LLC-PK1 Cells; Membrane Potentials; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Ouabain; Phenethylamines; Psychotropic Drugs; Swine; Symporters; Time Factors; Tyramine; Valinomycin; Veratridine | 1998 |
Effects of serine mutations in transmembrane domain 7 of the human norepinephrine transporter on substrate binding and transport.
Topics: Animals; Biological Transport; Carrier Proteins; COS Cells; Dopamine; Electrodes; Fluoxetine; Humans; Hydrogen Bonding; Kinetics; Mutagenesis, Site-Directed; Norepinephrine Plasma Membrane Transport Proteins; Protein Binding; Protein Structure, Tertiary; Radioligand Assay; Serine; Symporters; Tritium; Tyramine | 1999 |